US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.8500
  • +0.0300+1.65%
Close Dec 13 16:00 ET
  • 1.8400
  • -0.0100-0.54%
Post 19:52 ET
403.64MMarket Cap-8.41P/E (TTM)

About Akebia Therapeutics Company

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Company Profile

SymbolAKBA
Company NameAkebia Therapeutics
Listing DateMar 20, 2014
Issue Price17.00
Founded2007
CEOMr. John P. Butler
MarketNASDAQ
Employees167
Fiscal Year Ends12-31
Address245 First Street,Suite 1400
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-871-2098

Company Executives

  • Name
  • Position
  • Salary
  • John P. Butler
  • Director, President and Chief Executive Officer
  • 2.78M
  • Richard C. Malabre
  • Chief Accounting Officer
  • --
  • Nicholas Grund
  • Senior Vice President and Chief Commercial Officer
  • --
  • Erik John Ostrowski
  • Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
  • --
  • Dr. Steven Keith Burke, M.D.
  • Senior Vice President, Research and Development and Chief Medical Officer
  • 1.21M
  • Adrian Adams
  • Chairman of the Board
  • 171.63K
  • LeAnne M. Zumwalt
  • Independent Director
  • 143.31K
  • Ronald E. Frieson
  • Independent Director
  • 147.97K
  • Dr. Steven C. Gilman, PhD
  • Independent Director
  • 139.87K
  • Cynthia Smith
  • Independent Director
  • 151.50K
  • Michael W. Rogers
  • Independent Director
  • 145.79K
  • Dr. Myles Wolf, M.D.
  • Independent Director
  • 144.43K
Heat List
US
Overall
Symbol
Price
% Chg

No Data